Clinical Trials Browser

Phase 2 × Recruiting × Esthesioneuroblastoma, Olfactory × Clear all

NCT06176989 2025-10-20

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Phase 2 Recruiting

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06255210 2024-02-13

ESICON

Phase 2 Recruiting

Esthesioneuroblastoma, Olfactory